Jane Street Group LLC Acquires New Shares in Hancock Jaffe Laboratories Inc (NASDAQ:HJLI)

Jane Street Group LLC acquired a new stake in Hancock Jaffe Laboratories Inc (NASDAQ:HJLI) in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund acquired 77,915 shares of the company’s stock, valued at approximately $81,000. Jane Street Group LLC owned about 0.43% of Hancock Jaffe Laboratories at the end of the most recent quarter.

Several research firms recently issued reports on HJLI. ValuEngine lowered shares of Hancock Jaffe Laboratories from a “buy” rating to a “hold” rating in a research note on Thursday, September 26th. Zacks Investment Research lowered shares of Hancock Jaffe Laboratories from a “buy” rating to a “hold” rating in a research note on Wednesday, June 26th. Finally, Maxim Group reaffirmed a “buy” rating and issued a $3.00 price objective on shares of Hancock Jaffe Laboratories in a research note on Thursday, August 15th.

HJLI stock opened at $0.64 on Thursday. Hancock Jaffe Laboratories Inc has a 1 year low of $0.58 and a 1 year high of $3.45. The company has a quick ratio of 2.46, a current ratio of 2.46 and a debt-to-equity ratio of 0.15. The company has a fifty day simple moving average of $0.88 and a 200 day simple moving average of $1.35.

Hancock Jaffe Laboratories (NASDAQ:HJLI) last announced its earnings results on Monday, August 5th. The company reported ($0.13) EPS for the quarter. Hancock Jaffe Laboratories had a negative return on equity of 207.10% and a negative net margin of 5,250.79%.

About Hancock Jaffe Laboratories

Hancock Jaffe Laboratories, Inc, a development stage medical device company, develops and sells biological tissue solutions to treat patients with coronary, vascular, end stage renal, and peripheral arterial diseases in the United States and Europe. The company develops and manufactures implantable cardiovascular bioprosthetic devices for patients with cardiovascular disease, peripheral arterial and venous disease, and end stage renal disease.

See Also: Why do companies engage in swaps?

Receive News & Ratings for Hancock Jaffe Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hancock Jaffe Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.